Yu Yuefei, Pilgrim Petra, Yan Juqiang, Zhou Wei, Jenkins Marjorie, Gagliano Nicoletta, Bumm Klaus, Cannon Martin, Milzani Aldo, Dalle-Donne Isabella, Kast W Martin, Cobos Everardo, Chiriva-Internati Maurizio
Division of Hematology & Oncology, Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center, Lubbock, TX, USA.
J Transl Med. 2008 Oct 5;6:56. doi: 10.1186/1479-5876-6-56.
Recent studies demonstrate that recombinant adeno-associated virus (rAAV)-based antigen loading of dendritic cells (DCs) generates in vitro, significant and rapid cytotoxic T-lymphocyte (CTL) responses against viral antigens.
We used the rAAV system to induce specific CTLs against CVM antigens for the development of cytomegalovirus HCMV) gene therapy. As an extension of the versatility of the rAAV system, we incorporated immediate-early 1 (IE1), expressed in HCMV. Our rAAV vector induced a strong stimulation of CTLs directed against the HCMV antigen IE1. We then investigated the efficiency of the CTLs in killing IE1 targeted cells.
A significant MHC Class I-restricted, anti-IE1-specific CTL killing was demonstrated against IE1 positive peripheral blood mononuclear cells (PBMC) after one, in vitro, stimulation.
In summary, single PBMC stimulation with rAAV/IE1 pulsed DCs induces strong antigen specific-CTL generation. CTLs were capable to lyse low doses of peptides pulsed into target cells. These data suggest that AAV-based antigen loading of DCs is highly effective for generating human CTL responses against HCMV antigens.
近期研究表明,基于重组腺相关病毒(rAAV)的树突状细胞(DC)抗原负载可在体外产生针对病毒抗原的显著且快速的细胞毒性T淋巴细胞(CTL)反应。
我们使用rAAV系统诱导针对巨细胞病毒(HCMV)抗原的特异性CTL,以开发HCMV基因疗法。作为rAAV系统多功能性的扩展,我们纳入了在HCMV中表达的立即早期1(IE1)。我们的rAAV载体强烈刺激了针对HCMV抗原IE1的CTL。然后,我们研究了CTL杀伤IE1靶向细胞的效率。
在体外进行一次刺激后,针对IE1阳性外周血单个核细胞(PBMC),证实了显著的MHC I类限制性、抗IE1特异性CTL杀伤作用。
总之,用rAAV/IE1脉冲DC对PBMC进行单次刺激可诱导产生强烈的抗原特异性CTL。CTL能够裂解脉冲到靶细胞中的低剂量肽。这些数据表明,基于AAV的DC抗原负载对于产生针对HCMV抗原的人类CTL反应非常有效。